Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

(2014) M. J. Dolton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

(2013) Seyedmojtaba Seyedmousavi et al.   Expert Review of Anti-Infective Therapy

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

(2013) H. R. Ashbee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection

(2012) Oliver A. Cornely et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit

(2012) Dominic Störzinger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome

(2012) J. J. Vehreschild et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies

(2012) Martin Hoenigl et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Implementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model)

(2012) Jun Shen et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Posaconazole Treatment in Hematology Patients

(2012) Marie-Rose B. S. Crombag et al.   THERAPEUTIC DRUG MONITORING

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole

(2011) Jeroen Walravens et al.   CLINICAL PHARMACOKINETICS

Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections

(2011) O A Cornely et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake

(2011) C. Eiden et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis

(2011) Alexander M. Bryant et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Posaconazole Plasma Concentrations in Critically Ill Patients

(2011) John Ray et al.   THERAPEUTIC DRUG MONITORING

Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview

(2010) Hans-Peter Lipp   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Rifampin and Posaconazole Coadministration Leads to Decreased Serum Posaconazole Concentrations

(2010) Carina Hohmann et al.   CLINICAL INFECTIOUS DISEASES

Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma

(2010) S H Jang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers

(2010) R. J. M. Bruggemann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers

(2009) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers

(2009) E. S. Dodds Ashley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation

(2009) V. Kohl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

(2009) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene

(2009) E. Mavridou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults

(2009) D. Lebeaux et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome

(2009) M.A. AbuTarif et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

(2008) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome

(2008) Gopal Krishna et al.   PHARMACOTHERAPY